Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement. - Wikidata - thesis-toulmin - TriplyDB

Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.

Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.

http://www.wikidata.org/entity/Q37961072

about

Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.

P2860

Q38838470-3E0C28C2-DAD4-4579-8741-C38A3BA65C1F

P2860

Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.

http://www.wikidata.org/entity/Q37961072

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of psoriasis in Afr ...... opportunities for improvement.

@en

Management of psoriasis in Afr ...... opportunities for improvement.

@nl

type

label

Management of psoriasis in Afr ...... opportunities for improvement.

@en

Management of psoriasis in Afr ...... opportunities for improvement.

@nl

prefLabel

Management of psoriasis in Afr ...... opportunities for improvement.

@en

Management of psoriasis in Afr ...... opportunities for improvement.

@nl

P1433

Q37961072-BE17913B-771B-4D53-B026-80F64DC89F74

P1476

Q37961072-1532D1F4-60E0-4FF5-BC2F-D1AC854DFB74

P2093

Q37961072-077C80EC-2D97-46B1-8B0D-2474D194E312

Q37961072-1DF2D87F-2576-4A54-AF24-125B95F25A66

Q37961072-283D14C3-726D-4440-9AFA-BDA18A95CF44

Q37961072-330352F3-DF3E-49D8-A35F-084D1C95B53C

Q37961072-33B799CE-B89E-4F55-86E0-21A475C025CB

Q37961072-486ABD80-7FE1-4094-B269-B883EE48F1D3

Q37961072-4D7CB7CE-D703-4E2C-9F7C-C421FF28FA63

Q37961072-92D1E8BA-1E18-4279-9B11-829D0CD93089

Q37961072-B6A8F6C3-A50D-46E8-ABCD-9DEB61A69A40

Q37961072-DD15E208-B121-4DD4-971F-6D8F0F5C484F

P2860

Q37961072-0640E2A0-32D6-463E-A17B-1DB9F0198FF4

Q37961072-07D6945A-75AC-468F-A419-2BD0242AD209

Q37961072-08EC0840-DC30-4EF8-ADF7-D1ED15E34EA9

Q37961072-0DEDC5F5-674A-42A9-AF5A-02F050070746

Q37961072-0FFECA6F-5056-4DF8-8DCA-5B1ED58696B0

Q37961072-17D41640-1B28-4743-839E-A6720BAF2E6D

Q37961072-187C3216-7744-40CD-B55E-C5CE30183CFA

Q37961072-23B67DD0-3EEA-4149-9D70-11F8439FB7E3

Q37961072-26F2238C-E750-4EB7-8B70-A3AE31826019

Q37961072-2D16713D-6587-4796-8257-80A58AEB7E1D

P304

Q37961072-ECAF6157-5996-4B85-A840-62D7176E643D

P31

Q37961072-58912475-6D59-4145-80A4-3776AA5D79D7

P356

Q37961072-CAE6B0C4-F574-4B61-A44D-D6A45F3279F6

P433

Q37961072-1468C1FE-2F22-4C38-9898-847692F0E762

P478

Q37961072-7FC81FFB-D179-4593-BC2B-14CFDFC1FE81

P577

Q37961072-37AD9781-C84D-4C29-8CCA-8D1033418016

P5875

Q37961072-DE7FCE39-BDA8-4D6C-A0FA-762525536516

P698

Q37961072-B05A0A74-124E-43D4-B290-B608FD25328B

P921

Q37961072-8372608B-A927-43CF-8DF0-4F496711B167

P356

147323001103900501

P1433

Journal of International Medical Research

P1476

Management of psoriasis in Afr ...... opportunities for improvement.

@en

P2093

A Al Sheik

http://www.w3.org/2001/XMLSchema#string

A Ammoury

http://www.w3.org/2001/XMLSchema#string

A El Gendy

http://www.w3.org/2001/XMLSchema#string

D Odendaal

http://www.w3.org/2001/XMLSchema#string

D Thaçi

http://www.w3.org/2001/XMLSchema#string

D Whitaker

http://www.w3.org/2001/XMLSchema#string

F Behrens

http://www.w3.org/2001/XMLSchema#string

H Benchikhi

http://www.w3.org/2001/XMLSchema#string

I Benkaidali

http://www.w3.org/2001/XMLSchema#string

I Mokhtar

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Psoriasis: epidemiology, clinical features, and quality of life

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study.

Cost-effectiveness of psoriasis therapy with etanercept in Germany.

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.

Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.

Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature.

P304

1573-1588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/147323001103900501

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233574383

http://www.w3.org/2001/XMLSchema#string

P698

22117959

http://www.w3.org/2001/XMLSchema#string

P921